InvestorsHub Logo
Followers 6
Posts 1087
Boards Moderated 0
Alias Born 07/18/2006

Re: moosedogger post# 12402

Thursday, 03/04/2021 5:16:21 PM

Thursday, March 04, 2021 5:16:21 PM

Post# of 17422
If the KOLs Cowen referenced in today's webcast are right, we're golden!

They are predicting a 50% participation rate of eligible patients for Lupkynis.

There are 80,000 to 120,000 estimated LN sufferers in the USA.

It's estimated that 80% are candidates for Lupkynis.

Using the lower number of 80K pts x 80% x 50% (per KOL's) x 65K cost =

$2,080,000,000 estimated revenues!

It would be $3B annually if the 120K number is used!

The entire group today sounded very positive/upbeat!

KOLs = 'Key Opinion Leaders'


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News